Small Molecule CMO/CDMO Market Growth Is Accelerating As Industry Transformation Continues
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Small Molecule CMO/CDMO Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The market for small molecule CMO/CDMO services has experienced robust expansion in recent times, with its size climbing from $54.42 billion in 2025 to $58.55 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.6%. This historical upswing is largely driven by factors such as increased generic drug manufacturing, a growing incidence of chronic illnesses, broader pharmaceutical research and development activities, a greater reliance on outsourced drug production, and heightened regulatory emphasis on quality and safety standards.
The market for small molecule CMO/CDMO services is anticipated to experience robust expansion over the coming years, with projections indicating it will reach a valuation of $78.41 billion by 2030, advancing at a compound annual growth rate (CAGR) of 7.6%. This forecasted growth is fueled by a rising demand for personalized medicine, heightened investment in biologics and small-molecule hybrid treatments, expansion into emerging markets, progress in synthesis and formulation techniques, and a pressing need for faster regulatory approvals. Key developments shaping the forecast period involve the broadening of contract development and manufacturing offerings, a growing shift toward continuous manufacturing methods, increased custom synthesis of small-molecule active pharmaceutical ingredients (APIs), heightened emphasis on regulatory adherence and quality control, and the formation of strategic alliances between pharmaceutical companies and CMOs.
Download A Free Sample Report For Comprehensive Market Insights:
Small Molecule CMO/CDMO Market Demand Drivers: What Is Fueling Industry Growth?
The growing need for pharmaceutical products is anticipated to fuel the expansion of the small-molecule CMO/CDMO market in the coming years. This sector involves the discovery, development, and production of drugs and medicines by both public and private organizations. Within the pharmaceutical industry, small-molecule CMO/CDMO services are utilized to outsource tasks such as development, manufacturing, and packaging of small-molecule drugs, enabling companies to minimize costs, save time, and enhance operational efficiency. For example, Cardinal Health Inc., a US-based healthcare firm, reported in January 2023 that by January 2022, the U.S. had 33 FDA-approved biosimilar products, with 21 commercially available, and by 2023, the number of approved biosimilars had increased to 40, with 25 on the market. Consequently, the increasing demand for pharmaceuticals is propelling the growth of the small-molecule CMO/CDMO market.
Small Molecule CMO/CDMO Market Segment Breakdown: Which Categories Generate The Most Revenue?
The small molecule cmo/cdmo market covered in this report is segmented –
1) By Product: Small Molecule Drug Product, Small Molecule API
2) By Stage Type: Clinical, Commercial, Preclinical
3) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Cardiovascular Disease, Respiratory Disorders, Metabolic Disorders, Other Therapeutics
4) By Application: Cardiovascular, Oncology, Diabetes, Immunological Disorders
Subsegments:
1) By Small Molecule Drug Product: Solid Dosage Forms (Tablets, Capsules), Liquid Dosage Forms (Injectables, Solutions), Topical Dosage Forms
2) By Small Molecule API (Active Pharmaceutical Ingredient): Generic APIs, Branded APIs, Custom Synthesis APIs
Small Molecule CMO/CDMO Market Innovation Trends: Which Developments Are Transforming The Industry?
Key players within the small-molecule CMO/CDMO sector are placing increased emphasis on advanced technologies—especially the cutting-edge small-molecule platform in Shanghai—to enhance their CDMO service offerings. This platform represents the leading edge of technological progress, designed to facilitate the development and manufacturing of small-molecule drugs while enabling the creation of safer, more effective, and more efficiently manufactured pharmaceutical compounds. For example, in June 2023, Porton Pharma Solutions Ltd., a pharmaceutical firm based in China, unveiled a state-of-the-art small-molecule platform in Shanghai, aimed at upgrading its CDMO capabilities. Such a platform adopts a comprehensive strategy, merging sophisticated technologies and methodologies to support every stage of the small-molecule drug lifecycle, while delivering integrated one-stop-shop solutions, an end-to-end framework, operational flexibility and availability, as well as digital transformation.
Small Molecule CMO/CDMO Market Key Players And Strategic Industry Positioning
Major companies operating in the small molecule cmo/cdmo market are Patheon NV (Thermo Fisher Scientific), Johnson Matthey plc, Lonza Group Ltd., WuXi AppTec, Catalent Inc., Aurobindo Pharma, Fareva, Aesica Pharmaceuticals Limited, Siegfried holdings AG, Recipharm AB, Jubilant Life Sciences Limited, Almac Group, Piramal Pharma Solutions, Oxford Chemicals Inc., Syngene International Limited, Novasep, Pfizer CentreOne, GVK Biosciences, ChemPartner, Dishman Carbogen Amcis Ltd, ProChem Inc., Metrics Contract Services
Access The Complete Small Molecule CMO/CDMO Market Report:
Small Molecule CMO/CDMO Market Leading Geography: Which Region Generates The Most Revenue?
North America was the largest region in the small molecule CMO/CDMO market in 2025. The regions covered in the small molecule cmo/cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
